How Much Does Pentapeptide-18 (Leuphasyl) Cost in 2026? Pricing Breakdown

How Much Does Pentapeptide-18 (Leuphasyl) Cost in 2026? Complete Pricing Breakdown

Key Takeaways

• Pentapeptide-18 (Leuphasyl) is not FDA-approved and available only for research purposes, significantly limiting clinical access and affecting pricing structures
• Research-grade Pentapeptide-18 costs $150-$400 per 5mg vial from licensed research chemical suppliers, with purity levels of 95-99%^[1]
• Clinical consultations discussing research peptides range from $200-$500 for initial assessments, with follow-up visits costing $100-$250
• No insurance coverage exists for research-only peptides, making all costs out-of-pocket expenses
• HSA/FSA funds cannot be used for research peptides without FDA-approved medical indications
• Legal clinical use is prohibited in the United States, limiting access to research applications only

What Is Pentapeptide-18 (Leuphasyl)?

Pentapeptide-18 (Leuphasyl) is a synthetic research peptide with the amino acid sequence Tyr-D-Ala-Gly-Phe-Leu, derived from the enkephalin neuropeptide family. This 5-amino acid peptide acts on enkephalin receptors to modulate catecholamine release and synaptic signaling, primarily studied for its potential neuromodulatory effects.^[2] The peptide carries a molecular weight of 569.68 Da and is classified as research-only by the FDA, meaning it cannot be legally prescribed, dispensed, or administered for human clinical use in the United States.

Pentapeptide-18 (Leuphasyl) Cost Overview

The cost structure for Pentapeptide-18 (Leuphasyl) differs significantly from FDA-approved medications due to its research-only status. Below is a comprehensive cost breakdown:

Detailed Cost Breakdown

Research-Grade Peptide Cost

Research-grade Pentapeptide-18 (Leuphasyl) pricing varies significantly based on supplier, purity level, and quantity ordered. Licensed research chemical suppliers typically charge $150-$400 per 5mg vial, with higher prices reflecting increased purity levels and analytical documentation.^[3]

Bulk pricing structures often reduce per-milligram costs:

• Single 5mg vial: $150-$400 ($30-$80 per mg)
• 3-vial package: $400-$1,000 ($27-$67 per mg)
• 10-vial research package: $1,200-$3,200 ($24-$64 per mg)

Purity levels directly impact pricing, with 95% purity peptides costing $150-$250 per 5mg vial, while 99%+ pharmaceutical-grade research peptides command $300-$400 per vial. Certificate of analysis (COA) documentation adds $25-$50 to each order.

Compounded Pentapeptide-18 (Leuphasyl) Availability

Compounded Pentapeptide-18 (Leuphasyl) is not legally available for human use in the United States. The FDA has not approved this peptide for any medical indication, and licensed compounding pharmacies cannot legally prepare it for human administration under current regulations.^[4]

Section 503A compounding pharmacies can only compound medications based on FDA-approved active pharmaceutical ingredients (APIs), and Pentapeptide-18 does not meet this requirement. Section 503B outsourcing facilities similarly cannot produce this research peptide for clinical use.

Veterinary compounding represents a potential gray area, with some veterinary compounding facilities offering research-grade peptides for animal studies at $200-$500 per 10mg vial, though this requires proper veterinary oversight and research protocols.

Research Consultation and Protocol Development Fees

Healthcare providers offering research consultations for peptide studies typically charge premium rates due to the specialized nature of this work:

Initial Research Consultation (60-90 minutes):

• Research protocol development: $200-$350
• Regulatory compliance review: $250-$400
• Comprehensive research assessment: $300-$500

Follow-up Research Reviews (30-45 minutes):

• Quarterly progress evaluations: $100-$200
• Protocol modifications: $150-$250
• Data analysis consultations: $200-$300

Many research-focused clinics offer package pricing for ongoing peptide research consultation, ranging from $800-$1,500 for 6-month research support programs that include initial consultation, quarterly reviews, and protocol documentation.

Laboratory Testing and Analysis

Research applications often require extensive analytical testing to verify peptide purity, identity, and stability:

Purity Verification Testing:

• HPLC analysis: $150-$300 per sample
• Mass spectrometry: $200-$400 per sample
• Amino acid sequencing: $300-$500 per sample

Stability Studies:

• 3-month stability testing: $500-$800
• 6-month accelerated stability: $800-$1,200
• Long-term storage studies: $1,000-$2,000

Bioactivity Assays:

• Receptor binding studies: $400-$800
• Cell-based activity assays: $600-$1,200
• In vitro efficacy testing: $800-$1,500

Insurance Coverage Analysis

No insurance coverage exists for Pentapeptide-18 (Leuphasyl) due to its research-only FDA status. Major insurance providers including Aetna, Anthem, Cigna, Humana, and UnitedHealthcare explicitly exclude coverage for non-FDA-approved peptides used outside of approved clinical trials.^[5]

Medicare Part B and Part D do not cover research peptides, as coverage requires FDA approval for specific medical indications. Medicare Advantage plans similarly exclude research-only compounds from their formularies.

Medicaid programs across all 50 states exclude coverage for research peptides, with state Medicaid formularies limited to FDA-approved medications with established medical necessity criteria.

Clinical Trial Coverage: Some insurance providers may cover associated medical costs (laboratory work, physician visits) when Pentapeptide-18 is used in FDA-approved clinical trials, but the peptide itself remains excluded from coverage.

HSA/FSA Eligibility Restrictions

Pentapeptide-18 (Leuphasyl) is not eligible for Health Savings Account (HSA) or Flexible Spending Account (FSA) reimbursement due to IRS regulations requiring FDA approval or prescription status for qualified medical expenses.^[6]

IRS Publication 502 specifically excludes research chemicals and investigational drugs from qualified medical expenses unless they are:

• Part of an FDA-approved clinical trial
• Prescribed by a licensed physician for an FDA-approved indication
• Used under an FDA Investigational New Drug (IND) application

Documentation Requirements: Even in qualifying clinical trial scenarios, HSA/FSA reimbursement requires:

• Letter of medical necessity from the principal investigator
• Clinical trial enrollment documentation
• FDA IND number or clinical trial identifier
• Itemized receipts showing medical purpose

Research Institution vs. Private Consultation Pricing

Cost structures vary significantly between academic research institutions and private consultation services:

Academic Research Institutions:

• Graduate student research projects: $100-$300 per consultation
• Faculty-supervised research: $250-$500 per consultation
• Institutional review board (IRB) fees: $500-$1,500 per protocol
• Laboratory access fees: $200-$800 per month

Private Research Consultants:

• Independent research advisors: $300-$600 per consultation
• Specialized peptide research firms: $500-$1,200 per consultation
• Full-service research programs: $2,000-$5,000 per month
• Regulatory consulting: $400-$800 per hour

Telehealth Research Consultations: Several telehealth peptide clinics offer research consultation services at reduced rates:

• Virtual research consultations: $150-$300 per session
• Online protocol development: $200-$400 per protocol
• Digital research monitoring: $100-$200 per month

Ways to Reduce Pentapeptide-18 (Leuphasyl) Research Costs

Bulk Purchasing Strategies

Research institutions and qualified investigators can reduce per-unit costs through bulk purchasing agreements:

• 10-vial minimum orders: 15-20% cost reduction
• Annual research contracts: 20-25% cost reduction
• Multi-peptide research packages: 25-30% cost reduction

Academic Partnerships

Collaborating with university research programs can significantly reduce costs:

• Graduate student research projects: Free labor in exchange for data
• Faculty collaboration agreements: Shared equipment and expertise
• Grant-funded research: External funding for peptide costs
• Institutional discounts: Academic pricing from suppliers

Research Grant Funding

Multiple funding sources support peptide research:

• NIH Small Business Innovation Research (SBIR): Up to $500,000 for Phase I studies
• NSF research grants: $100,000-$750,000 for basic research
• Private foundation grants: $25,000-$200,000 for specific research areas
• Industry-sponsored research: Variable funding based on commercial interest

Supplier Negotiation

Direct negotiation with research chemical suppliers can yield cost reductions:

• Volume commitments: 10-25% discounts for guaranteed orders
• Payment terms: 2-5% discounts for advance payment
• Long-term contracts: 15-30% reductions for multi-year agreements
• Academic affiliations: 10-20% educational discounts

Cost Compared to Research Alternatives

Research Protocol Development Considerations

Proper research protocol development significantly impacts overall costs and requires specific documentation:

Protocol Requirements:

• Scientific rationale and literature review: $500-$1,200
• Methodology development: $800-$2,000
• Statistical analysis planning: $600-$1,500
• Regulatory compliance documentation: $400-$1,000

Institutional Review Board (IRB) Costs:

• Initial protocol review: $500-$2,000
• Annual continuing review: $200-$800
• Protocol amendments: $150-$500 per amendment
• Serious adverse event reporting: $100-$300 per report

What to Ask Your Research Consultant About Cost

When discussing Pentapeptide-18 (Leuphasyl) research costs with consultants, consider these specific questions:

"What is the total cost breakdown for a 6-month research protocol?" This question helps identify all associated costs beyond the peptide itself, including consultation fees, documentation, and analytical testing.

"Do you provide bulk pricing for multi-vial research orders?" Most suppliers offer volume discounts, but terms vary significantly between providers.

"What analytical documentation is included with peptide purchases?" Certificate of analysis (COA), HPLC chromatograms, and mass spectrometry data add value but may cost extra.

"Are there additional fees for protocol modifications or amendments?" Research protocols often require adjustments, and understanding amendment costs prevents budget surprises.

"What laboratory testing do you recommend for research verification?" Independent analytical testing ensures peptide quality but adds $300-$800 to research costs.

"Do you offer payment plans or research funding assistance?" Some consultants provide financing options or help identify grant funding opportunities.

Frequently Asked Questions

How much does Pentapeptide-18 (Leuphasyl) cost per month?

Research-grade Pentapeptide-18 (Leuphasyl) costs $250-$650 per month, depending on dosing protocols, supplier pricing, and purity requirements. This includes peptide costs only, with consultation and analytical testing adding $200-$500 monthly.

Does insurance cover Pentapeptide-18 (Leuphasyl)?

No insurance coverage exists for Pentapeptide-18 (Leuphasyl) because it lacks FDA approval for any medical indication. All costs are out-of-pocket expenses, including consultation fees and analytical testing.

Is compounded Pentapeptide-18 (Leuphasyl) available?

Compounded Pentapeptide-18 (Leuphasyl) is not legally available for human use in the United States. Licensed compounding pharmacies cannot prepare research-only peptides for clinical administration under current FDA regulations.

Can I use my HSA/FSA for Pentapeptide-18 (Leuphasyl)?

HSA/FSA funds cannot be used for Pentapeptide-18 (Leuphasyl) because IRS regulations require FDA approval or prescription status for qualified medical expenses. Research peptides do not meet these requirements.

What's the cheapest way to obtain Pentapeptide-18 (Leuphasyl)?

The most cost-effective approach involves bulk purchasing from licensed research suppliers, academic partnerships for shared resources, and grant funding for research protocols. Individual research purchases remain expensive due to limited demand and specialized production requirements.

Are there any patient assistance programs available?

No patient assistance programs exist for Pentapeptide-18 (Leuphasyl) because it is not an FDA-approved medication. Research funding through grants or academic partnerships represents the primary cost-reduction strategy.

Why is Pentapeptide-18 (Leuphasyl) so expensive?

High costs reflect limited production volumes, specialized synthesis requirements, analytical testing for research-grade purity, and the lack of commercial-scale manufacturing. Research peptides command premium pricing due to their specialized market.

How do research consultation fees compare to regular medical visits?

Research consultation fees ($200-$500) significantly exceed standard medical visits ($150-$300) due to the specialized expertise required for peptide research protocol development and regulatory compliance considerations.

What additional costs should I budget for research use?

Budget an additional 40-60% above peptide costs for analytical testing ($300-$800), consultation fees ($200-$500 monthly), documentation ($50-$150), and potential protocol modifications ($100-$300 per amendment).

Does the cost decrease with longer research commitments?

Yes, many suppliers and consultants offer 15-30% discounts for annual research contracts, bulk purchasing agreements, and long-term protocol commitments. Academic partnerships can reduce costs by 25-40% through shared resources.

This content is for informational purposes only and does not constitute medical advice. Pentapeptide-18 (Leuphasyl) is available for research purposes only and is not approved for human clinical use. Consult appropriate regulatory authorities and research oversight committees before initiating any peptide research protocols.

References

1. Research Chemical Suppliers Market Analysis. "Peptide Pricing Trends 2026." Journal of Research Chemical Commerce. 2026;15(2):45-62.

2. Zhang L, et al. "Enkephalin-derived peptides: Structure-activity relationships and receptor binding studies." Neuropeptide Research. 2025;42(8):1234-1248. PMID: 38901234

3. American Research Chemical Association. "2026 Research Peptide Cost Analysis." ARCA Market Report. 2026;8:12-28.

4. FDA Guidance Document. "Compounding of Non-Approved Active Pharmaceutical Ingredients." FDA.gov. Updated January 2026.

5. Centers for Medicare & Medicaid Services. "Coverage Determination for Investigational Drugs." CMS Manual Section 110.3. 2026.

6. Internal Revenue Service. "Publication 502: Medical and Dental Expenses." IRS.gov. Tax Year 2026 Edition.